AIMT - Aimmune Therapeutics Inc
Previous close
34.49
0 0%
Share volume: 565,218
Last Updated: Mon 12 Oct 2020 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$34.49
0.00
0.00%
Summary score
31%
Profitability
18%
Dept financing
11%
Liquidity
70%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-24.45%
Return on assets
-17.37%
Return on sales
-14831.83%
Return on invested capital
-149.13%
Total debt ratio
20.87%
Debt ratio change over timeo
-1.01%
Current Ratio
10.08%
Quick Ratio
7.7%
Cash Position Ratio
4.48%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-45.45%
Return on assets
-24.29%
Return on sales
-14831.83%
Return on invested capital
116.07%
Total debt ratio
45.61%
Debt ratio change over timeo
-1.04%
Current Ratio
5.85%
Quick Ratio
7.7%
Cash Position Ratio
4.05%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-38.5%
Return on assets
-18.07%
Return on sales
0%
Return on invested capital
5106.49%
Total debt ratio
50.76%
Debt ratio change over time
-1.04%
Current Ratio
7.53%
Quick Ratio
7.4%
Cash Position Ratio
6.2%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-97.88%
Return on assets
-98.35%
Return on sales
1639.08%
Return on invested capital
-133.7%
Total debt ratio
-101.48%
Debt ratio change over time
-1.01%
Current Ratio
-4.28%
Quick Ratio
-1.76%
Cash Position Ratio
-2.22%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AIMT | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -24.45% | 0% | 0% | 29.06% |
| Return on assets | -17.37% | 0% | 0% | -9.75% |
| Return on sales | -14831.83% | 0% | 0% | -1469.44% |
| Return on invested capital | -149.13% | 0% | 0% | 47.78% |
| Profitability | 0% | 0% | 50% | 50% |
| Total debt ratio | 20.87% | 0% | 0% | 183.15% |
| Debt ratio change over time | -1.01% | 0% | 0% | 19.02% |
| Dept financing | 3% | 0% | 0% | 50% |
| Current Ratio | 5.85% | 0% | 0% | 5.9% |
| Quick Ratio | 7.7% | 0% | 0% | 5.9% |
| Cash Position Ratio | 4.05% | 0% | 0% | 5.68% |
| Liquididy | 75% | 0% | 0% | 47% |
| Short-term ratios | AIMT | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -45.45% | 0% | 0% | -16.12% |
| Return on assets | -24.29% | 0% | 0% | -14.95% |
| Return on sales | -14831.83% | 0% | 0% | -3498.94% |
| Return on invested capital | 116.07% | 0% | 0% | 96.56% |
| Profitability | 25% | 0% | 75% | 21% |
| Total debt ratio | 45.61% | 0% | 0% | 79.61% |
| Debt ratio change over time | -1.04% | 0% | 0% | 0.09% |
| Dept financing | 14% | 0% | 0% | 50% |
| Current Ratio | 5.85% | 0% | 0% | 5.9% |
| Quick Ratio | 7.7% | 0% | 0% | 5.9% |
| Cash Position Ratio | 4.05% | 0% | 0% | 5.68% |
| Liquididy | 68% | 0% | 0% | 69% |